EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control

Lukas-Adrian Gurzeler, Marion Link, Yvonne Ibig, Isabel Schmidt, Olaf Galuba, Julian Schoenbett, Christelle Gasser-Didierlaurant, Christian N Parker, Xiaohong Mao, Francis Bitsch, Markus Schirle, Philipp Couttet und 7 weitere

Cell Reports · 2023-09 · 42 (9) · 113056

DOI: 10.1016/j.celrep.2023.113056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-09. Verfasst von Lukas-Adrian Gurzeler und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical…. Hauptthemen laut MEDLINE: Protein Biosynthesis, Cystic Fibrosis. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kanton Bern, Novartis, nccr – on the move.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Suppression of premature termination codons (PTCs) by translational readthrough is a promising strategy to treat a wide variety of severe genetic diseases caused by nonsense mutations. Here, we present two potent readthrough promoters-NVS1.1 and NVS2.1-that restore substantial levels of functional full-length CFTR and IDUA proteins in disease models for cystic fibrosis and Hurler syndrome, respectively. In contrast to other readthrough promoters that affect stop codon decoding, the NVS compounds stimulate PTC suppression by triggering rapid proteasomal degradation of the translation termination factor eRF1. Our results show that this occurs by trapping eRF1 in the terminating ribosome, causing ribosome stalls and subsequent ribosome collisions, and activating a branch of the ribosome-associated quality control network, which involves the translational stress sensor GCN1 and the catalytic activity of the E3 ubiquitin ligases RNF14 and RNF25.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein BiosynthesisCystic FibrosisHumansCodon, TerminatorCodon, NonsenseRibosomes

Stichwörter der Autor:innen

CFTRCP: Molecular biologyE3 ligaseGCN1Hurler syndromeIDUARNF14RNF25RQCcystic fibrosiseRF1proteasomal degradationreadthrough promoterribosome collisionsubiquitination

Substanzen

Codon, TerminatorCodon, Nonsense

Autor:innen und Institutionen

  • Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research, University of Bern, Bern, Switzerland.
  • Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland. Electronic address: oliver.muehlemann@unibe.ch.
  • Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: juergen.reinhardt@novartis.com.

Förderung

  • Kanton Bern
  • Novartis
  • nccr – on the move
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • National Institute of Biological Resources
  • University of Bern

Zitieren

APA

Gurzeler, L. A., Link, M., Ibig, Y., Schmidt, I., Galuba, O., Schoenbett, J., Gasser-Didierlaurant, C., Parker, C. N., Mao, X., Bitsch, F., Schirle, M., Couttet, P., Sigoillot, F., Ziegelmüller, J., Uldry, A. C., Teodorowicz, W., Schmiedeberg, N., Mühlemann, O., & Reinhardt, J. (2023). Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control. Cell Reports, 42(9), 113056. https://doi.org/10.1016/j.celrep.2023.113056

Vancouver

Gurzeler LA, Link M, Ibig Y, Schmidt I, Galuba O, Schoenbett J, et al. Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control. Cell Reports. 2023;42(9):113056. doi:10.1016/j.celrep.2023.113056

BibTeX
@article{Gurzeler2023,
  author = {Gurzeler, Lukas-Adrian and Link, Marion and Ibig, Yvonne and Schmidt, Isabel and Galuba, Olaf and Schoenbett, Julian and Gasser-Didierlaurant, Christelle and Parker, Christian N and Mao, Xiaohong and Bitsch, Francis and Schirle, Markus and Couttet, Philipp and Sigoillot, Frederic and Ziegelmüller, Jana and Uldry, Anne-Christine and Teodorowicz, Wojciech and Schmiedeberg, Niko and Mühlemann, Oliver and Reinhardt, Jürgen},
  title = {Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {9},
  pages = {113056},
  doi = {10.1016/j.celrep.2023.113056}
}
Kostenlos starten →